Evaluation and management of pediatric drug allergic reactions

Current Allergy and Asthma Reports

Volumn 7, Issue 6, 2007, Pages 402-409

  Buchmiller, Brett L ^b   Khan, David A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; BIOLOGIC AGENT; CARBAMAZEPINE; CARBOPLATIN; CEFACLOR; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; DAPSONE; IMATINIB; IMIPENEM; IMMUNOMODULATING AGENT; LORACARBEF; MEROPENEM; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PENICILLOYL POLYLYSINE; PHENYTOIN; PLATINUM COMPLEX; STREPTOMYCIN; TAXANE DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ACUTE OTITIS MEDIA; ALLERGY; ANAMNESIS; ANAPHYLAXIS; ARTHRALGIA; AUTOIMMUNITY; BRONCHOSPASM; BULLOUS SKIN DISEASE; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; CYTOPENIA; DESENSITIZATION; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG EXPOSURE; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; ERYTHEMA; ERYTHRODERMA; FLUSHING; GRAM NEGATIVE INFECTION; HUMAN; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; INTERSTITIAL NEPHRITIS; LIVER FUNCTION TEST; LYMPHADENOPATHY; MEASLES LIKE RASH; NAUSEA; NONHUMAN; PENICILLIN ALLERGY; PHYSICAL EXAMINATION; PRURITUS; RED MAN SYNDROME; REVIEW; RISK BENEFIT ANALYSIS; SERUM SICKNESS; SIDE EFFECT; SINUSITIS; SKIN ALLERGY; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; UNSPECIFIED SIDE EFFECT; URTICARIA; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL FACTORS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; SKIN TESTS;

EID: 35448960030     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0062-7     Document Type: Review

References (45)

1. Hazell L, Shakir SA: Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006, 29:385-396.
2. McKenna JK, Leiferman KM: Dermatologic drug reactions. Immunol Allergy Clin North Am 2004, 24:399-423, vi.
3. Gelfand JA, Elin RJ, Berry FW Jr, Frank MM: Endotoxemia associated with the Jarisch-Herxheimer reaction. N Engl J Med 1976, 295:211-213.
4. Pound MW, May DB: Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther 2005, 30:291-295.
5. Polk RE, Healy DP, Schwartz LB, et al.: Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 1988, 157:502-507.
6. Wallace MR, Mascola JR, Oldfield EC 3rd: Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis1991, 164:1180-1185.
7. Castells M: Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Curr Opin Allergy Clin Immunol 2006, 6:271-277.
8. Wazny LD, Daghigh B: Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 2001, 35:1458-1464.
9. Wakelin SH, Allen J, Zhou S, Wojnarowska F: Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 1998, 138:310-314.
10. Vidal C, Gonzalez Quintela A, Fuente R: Toxic epidermal necrolysis due to vancomycin. Ann Allergy 1992, 68:345-347.
11. Yung MW, Rajendra T: Delayed hypersensitivity reaction to topical aminoglycosides in patients undergoing middle ear surgery. Clin Otolaryngol Allied Sci 2002, 27:365-368.
12. Schretlen-Doherty JS, Troutman WG: Tobramycin-induced hypersensitivity reaction. Ann Pharmacother 1995, 29:704-706.
13. Morris SD, Rycroft RJ, White IR, et al.: Comparative frequency of patch test reactions to topical antibiotics. Br J Dermatol 2002, 146:1047-1051.
14. Green GR, Rosenblum AH, Sweet LC: Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 1977, 60:339-345.
15. Madaan A, Li JT: Cephalosporin allergy. Immunol Allergy Clin North Am 2004, 24:463-476, vi-vii.
16. Kelkar PS, Li JT: Cephalosporin allergy. N Engl J Med 2001, 345:804-809.
17. Daulat S, Solensky R, Earl HS, et al.: Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol 2004, 113:1220-1222.
18. American Academy of Pediatrics, Subcommittee on Management of Sinusitis and Committee on Quality Improvement: Clinical practice guideline: management of sinusitis. Pediatrics 2001, 108:798-808.
19. Pumphrey RS, Davis S: Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999, 353:1157-1158.
20. Romano A, Gueant-Rodriguez RM, Viola M, et al.: Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005, 35:1234-1242.
21. Romano A, Gueant-Rodriguez RM, Viola M, et al.: Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004, 141:16-22.
22. Saxon A, Adelman DC, Patel A, et al.: Imipenem cross-reactivity with penicillin in humans. J Allergy Clin Immunol 1988, 82:213-217.
23. Romano A, Viola M, Gueant-Rodriguez RM, et al.: Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007, 146:266-269.
24. Gueant JL, Gueant-Rodriguez RM, Viola M, et al.: IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 2006, 12:3335-3345.
25. Ditto AM: Drug allergy. In: Patterson's Allergic Diseases, edn 6. Edited by Grammer LC, Greenberger PA. Philadelphia: Lippincott Williams & Wilkins; 2002:295-385.
26. Murray DL, Singer DA, Singer AB, Veldman JP: Cefaclor-a cluster of adverse reactions. N Engl J Med 1980, 303:1003.
27. Solensky R, Earl HS, Gruchalla RS: Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002, 162:822-826.
28. Mendelson LM, Ressler C, Rosen JP, Seicow JE: Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 1984, 73:76-81.
29. Wolf R, Orion E, Marcos B, Matz H: Life-threatening acute adverse cutaneous drug reactions. Clin Dermatol 2005, 23:171-181.
30. Descamps V, Valance A, Edlinger C, et al.: Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001, 137:301-304.
31. Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P: Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol 2005, 4:510-513.
32. Payne AS, James WD, Weiss RB: Dermatologic toxicity of chemotherapeutic agents. Semin Oncol 2006, 33:86-97.
33. Quock J, Dea G, Tanaka M, et al.: Premedication strategy for weekly paclitaxel. Cancer Invest 2002, 20:666-672.
34. Markman M, Zanotti K, Peterson G, et al.: Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003, 21:4611-4614.
35. Morgan M, Bowers DC, Gruchalla RS, Khan DA: Safety and efficacy of repeated monthly carboplatin desensitization. J Allergy Clin Immunol 2004, 114:974-975.
36. Park MA, Volcheck GW, Guarderas JC: Successful progressive challenge after a cutaneous reaction to imatinib mesylate (Gleevec): a case report and review of the literature. Allergy Asthma Proc 2004, 25:345-347.
37. Pichler WJ: Adverse side-effects to biological agents. Allergy 2006, 61:912-920.
38. van Vollenhoven RF: Switching between biological agents. Clin Exp Rheumatol 2004, 22:S115-121.
39. Lee SJ, Kavanaugh A: Adverse reactions to biologic agents: focus on autoimmune disease therapies. J Allergy Clin Immunol 2005, 116:900-905.
40. Empedrad R, Darter AL, Earl HS, Gruchalla RS: Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003, 112:629-630.
41. Leguy-Seguin V, Jolimoy G, Coudert B, et al.: Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 2007, 119:726-730.
42. Shepherd G: Allergy to B-lactam antibiotics. Immunol Allergy Clin North Am 1991, 11:611.
43. Castells M: Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006, 6:476-481.
44. Farn AG, Dunne SM, Iazzetta J, Paton TW: Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Arthritis Rheum 2001, 44:231-238.
45. Lee-Wong M, Gadhvi D, Resnick D: Clopidogrel desensitization. Ann Allergy Asthma Immunol 2006, 96:756-757.